Oct 23, 2020, 08:56 by

https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-tissue-tek-smartconnect

Oct 23, 2020, 08:56 by

The new platform leverages machine learning to optimize a clinical trial’s chances of success, by analyzing patient population recruitment and dropout rate, as well as identifying and prioritizing monitored markers. It provides efficient pre-trial recommendations, in-trial interim analysis, and post-trial insights for next trial preparation, as well as potential salvage options in case of failure.

Oct 23, 2020, 08:56 by

MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc. has selected the Reportum QuickStart platform to streamline the capture, processing and management of safety data for the investigational drug voclosporin, following recent positive Phase 3 results.

Oct 23, 2020, 08:56 by

Atik Cameras today announced the launch of the VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments for accurate, reliable COVID-19 Testing – which I thought would be of interest to you and your readers. The qPCR test is vital in pinpointing COVID-19 positive cases and the timeframes in which these cases pose the greatest risk of spreading the SARS-CoV-2 virus to the wider population. With the paramount importance of the COVID-19 challenge, it was vital that Atik Cameras provided products that were well suited to the task. The commercially-competitive, custom VS255 and VS825 cameras offer superior sensitivity and image quality enabling Original Equipment Manufacturers (OEMs) and clinical diagnostic laboratories to achieve accurate diagnosis of active COVID-19 infections.

Oct 23, 2020, 08:56 by

A Dublin-based tech start-up today announced the launch of Wirano – a digital platform for the rapid and effective organization of clinical trials – which I thought would be of interest to you and your readers. The success rate of clinical trials is just 14%, with patient recruitment being a key hurdle. Wirano aims to improve this rate by optimizing the patient recruitment process, improving site and investigator selection procedures, and creating reliable channels for effective communication between all participants.

Oct 23, 2020, 08:56 by

Oct 23, 2020, 08:54 by

Global Genes, a leading rare disease patient advocacy organization, is pleased to announce a new partnership with Rady Children’s Institute for Genomic Medicine (RCIGM) to develop a next-generation support network for families with gene-based diagnosed rare diseases.

Oct 23, 2020, 08:54 by

Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Dr. Thomas A. Bock to its board of directors.

Oct 23, 2020, 08:54 by

Knowledge to Practice (K2P), a leading provider of personalized, competency-based lifelong learning for practicing physicians, hospitals and healthcare systems, today announced it has named David B. Nash, MD, MBA, as Chairman of its Advisory Board. A board-certified internist and the Founding Dean Emeritus at Jefferson College of Population Health, Dr. Nash advised on the development of the recently launched CurrentMD COVID curriculum and is helping to conceptualize K2P’s new Complex Diseases curriculum, set to launch in 2021.

Oct 23, 2020, 08:54 by

WCG has unified its five IRBs – Western IRB (WIRB), Copernicus Group IRB, Midlands IRB, New England IRB, and Aspire IRB – in a single brand, WCG IRB. It has also launched a new technology – WCG IRB Connexus – to support clients’ ethical review submissions and management. Further information is available on it new website at www.wcgirb.com.

Oct 23, 2020, 01:00 by User Not Found

Clinical Reserch News | Tocilizumab lowers in-hospital deaths, a global survey finds mixed responses to vaccine views and in the US they are driven partially by politics, and Monell Chemical Senses Center finds loss of smell more prevalent than we thought. Plus: the UK plans to develop a COVID-19 (SARS-CoV-2) human challenge study model, Texas launches a state-wide antibody study, and a call to action for the upcoming flu season.

Oct 22, 2020, 01:00 by User Not Found

Clinical Research News | Surging use of telemedicine technology since the COVID-19 pandemic hit the U.S. earlier this year has resulted in a massive influx of unstructured patient data to sort through when searching for drug safety signals and compiling adverse event reports required by federal regulators. Natural language processing (NLP) thus has a potentially bigger role to play in automating the pharmacovigilance process, starting with interpreting data in free text fields and doing some of the cumbersome analytical work.

Oct 20, 2020, 07:52 by User Not Found

Clinical Research News | In March, a group of date-sharing researchers assembled to review more than 10,000 COVID-19 publications, draft nine protocols, release 13 study packages, and assemble a distributed data network with 37 partners signed on to execute studies.

Oct 16, 2020, 00:00 by User Not Found

Clinical Research News I Group of 80 researchers warns against herd immunity approach, UK case of sudden hearing loss linked to COVID-19, 1 in 7 experience neurological injuries, blood type O may have lowest risk, significant percentage of mothers report increased insomnia and anxiety, 20% of young patients hospitalized require intensive care, NIH launches SeroNet to increase antibody testing capacity, MMR vaccine may offer trained immunity, and international open-access database aims to reduce duplication of research. Plus, over 200 molecules identified that impact severity of virus, UC Davis Health testing REGN-COV2 antibody ‘cocktail’, increase in US death rate unexplained by COVID-19 related deaths and more.

Oct 15, 2020, 00:00 by User Not Found

Clinical Research News | Merck’s Sylvia Marecki and Omesan Nair teamed up for a presentation on harnessing machine learning to identify causal drivers of enrollment success in clinical trials at the recent Bio-IT World Conference & Expo Virtual. The Operational Design Center (ODC) at EMD Serono, a Merck KGaA affiliate, uses analytics to address study-related business questions such as the anticipated duration of enrollment and how to speed up the process.

Oct 14, 2020, 00:00 by User Not Found

Clinical Research News | Broader adoption of digital biomarkers in clinical trials is dependent on their regulatory approval, and data quality remains the big hurdle, according to Ariel Dowling, director of digital strategy at Takeda Pharmaceuticals, who led a workshop on wearables at the recent Bio-IT World Conference & Expo Virtual. She presented two specific use cases of digital biomarkers for clinical validation and as a primary endpoint for internal decision-making.

Oct 9, 2020, 01:00 by User Not Found

Clinical Research News | Previous infection with a non-SARS-CoV-2 coronavirus may lessen severity COVID-19. Long term exposure to urban air pollution may have made COVID-19 more deadly for some. 86% of UK residents who tested positive this spring did not have the specific virus symptoms. And a new look at the interrelationship between COVID-19 and cancer. Plus, survey shows patients have concerns about their health and safety at in-office visits, TestBoston trial looks for previous infection, and Israel opens pediatric COVID-19 ward.

Oct 8, 2020, 14:24 by User Not Found

Clinical Research News | On a recent survey, nearly 80% of biopharma and device development execs said they plan to use, or are using, AI to improve R&D performance. At the same time, the COVID-19 pandemic has accelerated the industry’s adoption of Decentralized Clinical Trials (DCTs). As these two burgeoning technologies continue to mature, there is an opportunity for transformation in clinical research where AI and DCTs intersect.

Oct 5, 2020, 14:35 by User Not Found

Clinical Research News | Last month, the Leukemia & Lymphoma Society (LLS) and PRA Health Sciences announced their partnership in LLS’s first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia. The LLS PedAL (Pediatric Acute Leukemia) master clinical trial will simultaneously test multiple targeted therapies for children who experience a relapse of their acute leukemia. Now PRA has signed on as the contract research organization for the trial.

Oct 2, 2020, 10:29 by User Not Found

Clinical Research News | Case fatality rates among minorities questioned, vitamin D matters, ECMO saving lives, concerning genetic mutations, rise in anti-Asian racism, older adults excluded from trials, treatment potential of diabetes drug, rise in alcohol consumption, risks to mental health and men’s testosterone level, scary changes in care-seeking behavior, antibodies not eternal, pre-existing immunity may be widespread, younger cohorts dying in India, mostly men calling the shots, and delirium a key symptom among the elderly. Plus, a wealth of industry news that includes trials targeting nursing homes, launch of an eight-state patient data registry and an app to quantify mask-wearing behavior.